Article
p53 dosage impedes Kras <sup>G12D</sup> - and Kras <sup>Q61R</sup> -mediated tumorigenesis
2023-09-17
Abstract excerpt
Mice engineered with G12D versus Q61R mutant of Kras exhibit differences in the number and grade of tumors. Namely, the incidence or grade of oral or forestomach squamous epithelial lesions was more prevalent in the Kras G12D background while hematolymphopoietic disease was more prevalent in the Kras Q61R background. Loss of the Trp53 gene encoding p53 enhances the ability of oncogenic Kras to initiate tumorige...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7a1cf81a-2c87-53bd-a1d5-9b019d36182a
- DOI
- 10.1101/2023.09.17.558140
